Showing results (111-120 of 451) with videos related to

Sort By:
Pageof 46
International Journal of Cancer|September 15, 1990
Human melanoma cells with high susceptibility to cell-mediated lysis can be identified on the basis of ICAM-1 phenotype, VLA profile and invasive abilityA Anichini, R Mortarini, R Supino, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1990
Mouse tumors are heterogeneous in their susceptibility to syngeneic lymphokine-activated killer cells and delineate functional subsets in such effectorsM Sensi, L Grazioli, M Rodolfo, et al.
Melanoma Research|August 1, 1991
An autologous T cell clone overcomes intra-melanoma heterogeneity for susceptibility to cell-mediated lysis by using multiple lytic mechanisms: in vitro and in vivo analysisA Mazzocchi, M Rodolfo, G Parmiani, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Role of T cells and tumour necrosis factor in antitumour activity and toxicity of flavone acetic acidG Pratesi, M Rodolfo, G Rovetta, et al.
European Journal of Immunology|October 1, 1998
Induction and functional characterization of beta2-microglobulin (beta2-mu)-free HLA class I heavy chains expressed by beta2-mu-deficient human FO-1 melanoma cellsZ Wang, F Arienti, G Parmiani, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1991
Therapeutic use of a long-term cytotoxic T cell line recognizing a common tumour-associated antigen: the pattern of in vitro reactivity predicts the in vivo effect on different tumoursM Rodolfo, C Bassi, C Salvi, et al.
International Journal of Cancer|April 1, 1994
Multiple sub-sets of CD4+ and CD8+ cytotoxic T-cell clones directed to autologous human melanoma identified by cytokine profilesC Maccalli, R Mortarini, G Parmiani, et al.
Cancer Research|November 24, 2001
Phases of apoptosis of melanoma cells, but not of normal melanocytes, differently affect maturation of myeloid dendritic cellsG Pietra, R Mortarini, G Parmiani, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1988
Lack of cross-resistance of a doxorubicin-resistant B16 melanoma line with 4'-deoxy-4'-iodo-doxorubicinR Supino, M Mariani, E Prosperi, et al.
International Journal of Cancer|February 15, 1990
Cytokine-mediated modulation of HLA-class II, ICAM-1, LFA-3 and tumor-associated antigen profile of melanoma cells. Comparison with anti-proliferative activity by rIL1-beta, rTNF-alpha, rIFN-gamma, rIL4 and their combinationsR Mortarini, F Belli, G Parmiani, et al.
Pageof 46